BiotechTube
Home/Neuvogen/Todd Binder, MBA
TB

Todd Binder, MBA

Chief Executive Officer

Neuvogen

Therapeutic Areas

OncologySolid Tumors

Neuvogen Pipeline

DrugIndicationPhase
Undisclosed Whole Cell Vaccine Program(s)Solid TumorsPre-clinical

Leadership Team at Neuvogen

CO
Christian Ottensmeier, MD, PhD, FRCP
Acting Chief Scientific Officer
View full Neuvogen profile